Premium
Targeting IL‐10, ZO‐1 gene expression and IL‐6/STAT‐3 trans‐signalling by a combination of atorvastatin and mesalazine to enhance anti‐inflammatory effects and attenuate progression of oxazolone‐induced colitis
Author(s) -
Ribaldone Davide Giuseppe,
Vernero Marta,
Caviglia Gian Paolo
Publication year - 2021
Publication title -
fundamental and clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.655
H-Index - 73
eISSN - 1472-8206
pISSN - 0767-3981
DOI - 10.1111/fcp.12638
Subject(s) - oxazolone , mesalazine , stat , atorvastatin , cancer research , medicine , pharmacology , gene expression , immunology , signal transduction , gene , chemistry , biology , microbiology and biotechnology , stat3 , biochemistry , inflammatory bowel disease , disease